Hisashi Urushihara Selected Research

Levodopa (L Dopa)

1/2014

Prescribing pattern of anti-Parkinson drugs in Japan: a trend analysis from 2005 to 2010.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hisashi Urushihara Research Topics

Disease

4	Human Influenza (Influenza) 01/2022 - 01/2011
3	Pain (Aches) 12/2014 - 06/2007
2	Infections 01/2022 - 01/2014
2	Hemorrhage 01/2022 - 01/2019
2	Stevens-Johnson Syndrome (Lyell's Syndrome) 07/2021 - 01/2019
2	Stroke (Strokes) 01/2019 - 09/2009
2	Rheumatoid Arthritis 05/2015 - 07/2014
2	Osteoporosis 12/2014 - 09/2009
2	Parkinson Disease (Parkinson's Disease) 01/2014 - 01/2011
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2021
1	Chronic Renal Insufficiency 10/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Embolism (Embolus) 01/2019
1	Frailty 01/2019
1	Atrial Fibrillation 01/2019
1	Type 2 Diabetes Mellitus (MODY) 12/2018
1	Respiratory Tract Diseases (Respiratory Tract Disease) 11/2018
1	Pneumonia (Pneumonitis) 11/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2015
1	Vomiting 03/2015
1	Gastroenteritis 03/2015
1	Bronchitis 04/2014
1	Diarrhea 04/2014
1	Eczema 04/2014
1	Hepatitis 01/2014
1	Diabetes Mellitus 05/2013
1	Coronary Artery Disease (Coronary Atherosclerosis) 05/2013
1	Hypertension (High Blood Pressure) 05/2013
1	Cardiovascular Diseases (Cardiovascular Disease) 05/2013
1	Drug-Related Side Effects and Adverse Reactions 01/2013
1	Cough 01/2013
1	Postmenopausal Osteoporosis 11/2012
1	Aneuploidy (Aneuploid) 01/2012
1	Chromosomal Instability (Chromosome Stability) 01/2012
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2012

Drug/Important Bio-Agent (IBA)

6	Pharmaceutical PreparationsIBA 01/2019 - 01/2014
3	Raloxifene Hydrochloride (Evista)FDA Link 12/2014 - 09/2009
2	Oseltamivir (Tamiflu)FDA Link 01/2022 - 01/2011
2	ORALIT (ORS)IBA 07/2019 - 11/2018
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2014 - 01/2011
1	baloxavirIBA 01/2022
1	Zanamivir (Relenza)FDA Link 01/2022
1	peramivirIBA 01/2022
1	laninamivirIBA 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 07/2021
1	thiamine triphosphorate (TTP)IBA 01/2021
1	Docetaxel (Taxotere)FDA Link 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	AnticoagulantsIBA 01/2019
1	Warfarin (Coumadin)FDA LinkGeneric 01/2019
1	Cholinergic Antagonists (Anticholinergics)IBA 01/2019
1	Dabigatran FDA Link 01/2019
1	Hypnotics and Sedatives (Sedatives)IBA 01/2019
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2018
1	VaccinesIBA 11/2018
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2015
1	Gefitinib (Iressa)FDA Link 10/2015
1	Antirheumatic Agents (DMARD)IBA 05/2015
1	AntiemeticsIBA 03/2015
1	Domperidone (Domperidon)IBA 03/2015
1	Investigational DrugsIBA 07/2014
1	tocilizumab (atlizumab)FDA Link 07/2014
1	Palivizumab FDA Link 04/2014
1	Levodopa (L Dopa)FDA LinkGeneric 01/2014
1	Fibrinogen (Factor I)FDA Link 01/2014
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2013
1	Pravastatin (Pravachol)FDA LinkGeneric 05/2013
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2013
1	Angiotensin Receptor AntagonistsIBA 01/2013
1	Oxygen (Dioxygen)IBA 01/2012
1	Pergolide (Permax)FDA Link 01/2011
1	Cabergoline FDA LinkGeneric 01/2011
1	Insulin-Like Growth Factor I (IGF-1)IBA 06/2007

Therapy/Procedure

4	Therapeutics 01/2022 - 05/2013
2	Drug Therapy (Chemotherapy) 01/2021 - 05/2013
1	Renal Replacement Therapy (Therapies, Renal Replacement) 10/2021
1	Kidney Transplantation 10/2021
1	Castration 01/2021
1	Polypharmacy 01/2019
1	Fluid Therapy (Oral Rehydration Therapy) 03/2015
1	Activities of Daily Living (ADL) 12/2014